Amarin Stock Faces a Post-Holiday Test After Quiet Week and Cash-Flow Pledge
Amarin Corporation plc’s Nasdaq-listed American depositary shares, U.S.-traded certificates for foreign shares, head into a shortened trading week after a muted finish before the Memorial Day break, with investors still looking for proof that cost cuts and partner-led overseas sales can steady the heart-drug maker. U.S. equity markets, including Nasdaq, are closed Monday for Memorial Day and are due to reopen Tuesday, according to Nasdaq’s 2026 holiday calendar. That leaves Amarin’s Friday close as the latest regular-session price marker.